Medicine & Health

Researchers led by the McKelvey School of Engineering’s Hong Chen recently invented a technique for generating ultrasound waves that can self-bend, like a rainbow.

The world’s first nasal vaccine for COVID-19 was approved Sept. 6 in India for emergency use. The vaccine, called iNCOVACC, is based on technology licensed from Washington University and developed in collaboration with Bharat Biotech International Limited in India.

Ismael Seáñez received a five-year $1 million grant from the National Institutes of Health (NIH) to lead interdisciplinary spinal cord injury research.

Men with low testosterone who develop COVID-19 are at elevated risk of becoming seriously ill and ending up in the hospital, according to a study by researchers at Washington University School of Medicine and Saint Louis University School of Medicine.

A new study from Washington University School of Medicine suggests a simple blood test — administered before CAR-T cell treatment is initiated — may identify which patients are predisposed to developing neurotoxic side effects after CAR-T cell therapy, which is used to treat several cancers.

Three faculty from the Brown School and School of Medicine at Washington University in St. Louis have received a seven-year $6.1 million grant from the National Institutes of Health (NIH) for a project aimed at improving the health of mothers and children in the St. Louis region.

An experimental combination of two drugs halts the progression of small cell lung cancer, the deadliest form of lung cancer, according to a study in mice from researchers at Washington University School of Medicine in St. Louis and colleagues.

Research from the McKelvey School of Engineering and School of Medicine aims to overcome a critical barrier in kidney disease research with a new way to culture specific kidney cells.

Louis Woodhams and Phil Bayly’s team at the McKelvey School of Engineering built a model to better understand how certain cilia — tiny, hairlike structures throughout our body — beat.

Washington University School of Medicine and BJC HealthCare are partnering with CuriMeta, a new company based in St. Louis, that will accelerate lifesaving research in the fight against chronic and acute diseases.